It also fits with the anti-obesity effects of lowering insulin levels with diazoxide or octreotide, and with the prevention or remission of obesity with genetic downregulation of insulin production or insulin receptor expression on adipocytes in mice. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.